A true revolution in blood tests for cancer detection with cutting-edge technology capable of efficiently isolating and analyzing CTCs from blood. Its main advantages are the ability to isolate a single tumor cell from a pool of more than 50 billion cells; the automation of its processes, which avoids human error; the isolated tumor cells are compatible with traditional molecular biology techniques so that subsequent functional analysis can be performed; and that this technology was developed by the Delee team, which dramatically reduces the cost per unit, resulting in competitive prices.